Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Izidor Sosič

PhD Izidor Sosič
no.: 30816 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
855.22
A''
164.98
A'
450.47
A1/2
703.81
CI10
1,428
CImax
83
h10
21
A1
3.16
A3
0.04
Data for the last 5 years (citations for the last 10 years) on June 28, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 81  1,690  1,387  17.12 
Scopus 83  1,767  1,433  17.27 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Nika Strašek Benedik  Bologna doctoral studies  10/1/2020 - 9/30/2024  52378 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (120%, RD:60%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. N1-0331  A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases   2024  PhD Izidor Sosič  0 
2. J1-50037  Development of CDK1-selective degraders for the treatment of T-cell malignancies   2023 - 2024  PhD Izidor Sosič  0 
3. J3-50116  Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors   2023 - 2024  PhD Martina Gobec  0 
4. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  0 
5. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors   2022 - 2024  PhD Andrej Perdih  0 
6. J1-4400  Evaluation of transient protein states   2022 - 2024  PhD Simona Golič Grdadolnik  0 
7. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   2021 - 2024  PhD Stane Pajk  0 
8. N1-0169  Kovalentni pristop k boju proti bakterijski rezistenci (Slovene)   2021 - 2023  PhD Stanislav Gobec  0 
9. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   2020 - 2023  PhD Žiga Jakopin  0 
10. J1-2485  The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs   2020 - 2023  PhD Izidor Sosič  0 
11. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   2019 - 2023  PhD Tihomir Tomašić  0 
12. J3-1745  Elucidating the role of immunoproteasome in platelet-driven immune response   2019 - 2023  PhD Martina Gobec  0 
13. Z1-7181  Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer   2016 - 2017  PhD Izidor Sosič  0 
14. L1-6745  Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors   2014 - 2015  PhD Stanislav Gobec  0 
15. J1-6743  Computational tools development for modeling of pharmaceutically interesting molecules   2014 - 2015  PhD Dušanka Janežič  0 
16. J4-6811  The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells   2014 - 2015  PhD Janko Kos  0 
17. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2015  PhD Janko Kos  0 
18. L1-4039  Preclinical development of new antibacterial drugs   2011  PhD Stanislav Gobec  2 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2022 - 2024  PhD Stanislav Gobec  2 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   2015 - 2021  PhD Stanislav Gobec  2 
3. P1-0208  Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)   2009 - 2014  PhD Danijel Kikelj  2 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite